Hypolipidemic and antiatherogenic effects of Cynara scolymus in cholesterol-fed rats

Detalhes bibliográficos
Autor(a) principal: Mocelin,Ricieri
Data de Publicação: 2016
Outros Autores: Marcon,Matheus, Santo,Glaucia D., Zanatta,Leila, Sachett,Adrieli, Schönell,Amanda P., Bevilaqua,Fernanda, Giachini,Marta, Chitolina,Rafael, Wildner,Silvana M., Duarte,Marta M.M.F., Conterato,Greicy M.M., Piato,Angelo L., Gomes,Denise B., Roman Junior,Walter A.
Tipo de documento: Artigo
Idioma: eng
Título da fonte: Revista Brasileira de Farmacognosia (Online)
Texto Completo: http://old.scielo.br/scielo.php?script=sci_arttext&pid=S0102-695X2016000200233
Resumo: ABSTRACT Cynara scolymus L., Asteraceae, are traditionally used to treat dyspepsia. This study evaluated the hypolipidemic and antiatherogenic effects of an aqueous extract prepared from the leaves of C. scolymus in rat's model. Hypercholesterolemic rats (1% cholesterol and 0.5% cholic acid for 15 days) were treated (0.5 ml/200 g) with extract of C. scolymus (150, 300, or 600 mg/kg p.o.; n = 6) or simvastatin (4 mg/kg p.o.; n = 6) once per day for 30 days along with hypercaloric diet. A control group (C) was given water (0.5 ml/200 g; n = 6). A high-cholesterol diet was maintained throughout the treatment period. Rats treated with extract of C. scolymus (150, 300, or 600 mg/kg) and simvastatin showed significant decreases in serum levels of total cholesterol (−46.9%, −51.9%, −44%, and −41.9%, respectively) and low-density lipoprotein-cholesterol (LDL-C; −52.1%, −54.8%, −51.9%, and −46.7%, respectively), compared with group C (p < 0.005). Biochemical analyses revealed significant decrease in the concentration of IL-1, IL-6, TNF-α, IFN-γ, C-reactive protein, oxidized-LDL, and antioxidized-LDL in rats treated with extract of C. scolymus (150, 300, or 600 mg/kg). There were no differences in serum ALT enzyme activity between the groups. Our results suggest that hypolipidemic and antiatherogenic effects could be related with the presence of polar substances present in aqueous extract of C. scolymus.
id SBFGNOSIA-1_36a9d1ee12781c22b4ddb2e9d4ccceca
oai_identifier_str oai:scielo:S0102-695X2016000200233
network_acronym_str SBFGNOSIA-1
network_name_str Revista Brasileira de Farmacognosia (Online)
repository_id_str
spelling Hypolipidemic and antiatherogenic effects of Cynara scolymus in cholesterol-fed ratsAntihyperlipidemicAntiatherogenicArtichokeAsteraceaeCholesterolABSTRACT Cynara scolymus L., Asteraceae, are traditionally used to treat dyspepsia. This study evaluated the hypolipidemic and antiatherogenic effects of an aqueous extract prepared from the leaves of C. scolymus in rat's model. Hypercholesterolemic rats (1% cholesterol and 0.5% cholic acid for 15 days) were treated (0.5 ml/200 g) with extract of C. scolymus (150, 300, or 600 mg/kg p.o.; n = 6) or simvastatin (4 mg/kg p.o.; n = 6) once per day for 30 days along with hypercaloric diet. A control group (C) was given water (0.5 ml/200 g; n = 6). A high-cholesterol diet was maintained throughout the treatment period. Rats treated with extract of C. scolymus (150, 300, or 600 mg/kg) and simvastatin showed significant decreases in serum levels of total cholesterol (−46.9%, −51.9%, −44%, and −41.9%, respectively) and low-density lipoprotein-cholesterol (LDL-C; −52.1%, −54.8%, −51.9%, and −46.7%, respectively), compared with group C (p < 0.005). Biochemical analyses revealed significant decrease in the concentration of IL-1, IL-6, TNF-α, IFN-γ, C-reactive protein, oxidized-LDL, and antioxidized-LDL in rats treated with extract of C. scolymus (150, 300, or 600 mg/kg). There were no differences in serum ALT enzyme activity between the groups. Our results suggest that hypolipidemic and antiatherogenic effects could be related with the presence of polar substances present in aqueous extract of C. scolymus.Sociedade Brasileira de Farmacognosia2016-04-01info:eu-repo/semantics/articleinfo:eu-repo/semantics/publishedVersiontext/htmlhttp://old.scielo.br/scielo.php?script=sci_arttext&pid=S0102-695X2016000200233Revista Brasileira de Farmacognosia v.26 n.2 2016reponame:Revista Brasileira de Farmacognosia (Online)instname:Sociedade Brasileira de Farmacognosia (SBFgnosia)instacron:SBFGNOSIA10.1016/j.bjp.2015.11.004info:eu-repo/semantics/openAccessMocelin,RicieriMarcon,MatheusSanto,Glaucia D.Zanatta,LeilaSachett,AdrieliSchönell,Amanda P.Bevilaqua,FernandaGiachini,MartaChitolina,RafaelWildner,Silvana M.Duarte,Marta M.M.F.Conterato,Greicy M.M.Piato,Angelo L.Gomes,Denise B.Roman Junior,Walter A.eng2016-11-30T00:00:00Zoai:scielo:S0102-695X2016000200233Revistahttp://www.sbfgnosia.org.br/revista/https://old.scielo.br/oai/scielo-oai.phprbgnosia@ltf.ufpb.br1981-528X0102-695Xopendoar:2016-11-30T00:00Revista Brasileira de Farmacognosia (Online) - Sociedade Brasileira de Farmacognosia (SBFgnosia)false
dc.title.none.fl_str_mv Hypolipidemic and antiatherogenic effects of Cynara scolymus in cholesterol-fed rats
title Hypolipidemic and antiatherogenic effects of Cynara scolymus in cholesterol-fed rats
spellingShingle Hypolipidemic and antiatherogenic effects of Cynara scolymus in cholesterol-fed rats
Mocelin,Ricieri
Antihyperlipidemic
Antiatherogenic
Artichoke
Asteraceae
Cholesterol
title_short Hypolipidemic and antiatherogenic effects of Cynara scolymus in cholesterol-fed rats
title_full Hypolipidemic and antiatherogenic effects of Cynara scolymus in cholesterol-fed rats
title_fullStr Hypolipidemic and antiatherogenic effects of Cynara scolymus in cholesterol-fed rats
title_full_unstemmed Hypolipidemic and antiatherogenic effects of Cynara scolymus in cholesterol-fed rats
title_sort Hypolipidemic and antiatherogenic effects of Cynara scolymus in cholesterol-fed rats
author Mocelin,Ricieri
author_facet Mocelin,Ricieri
Marcon,Matheus
Santo,Glaucia D.
Zanatta,Leila
Sachett,Adrieli
Schönell,Amanda P.
Bevilaqua,Fernanda
Giachini,Marta
Chitolina,Rafael
Wildner,Silvana M.
Duarte,Marta M.M.F.
Conterato,Greicy M.M.
Piato,Angelo L.
Gomes,Denise B.
Roman Junior,Walter A.
author_role author
author2 Marcon,Matheus
Santo,Glaucia D.
Zanatta,Leila
Sachett,Adrieli
Schönell,Amanda P.
Bevilaqua,Fernanda
Giachini,Marta
Chitolina,Rafael
Wildner,Silvana M.
Duarte,Marta M.M.F.
Conterato,Greicy M.M.
Piato,Angelo L.
Gomes,Denise B.
Roman Junior,Walter A.
author2_role author
author
author
author
author
author
author
author
author
author
author
author
author
author
dc.contributor.author.fl_str_mv Mocelin,Ricieri
Marcon,Matheus
Santo,Glaucia D.
Zanatta,Leila
Sachett,Adrieli
Schönell,Amanda P.
Bevilaqua,Fernanda
Giachini,Marta
Chitolina,Rafael
Wildner,Silvana M.
Duarte,Marta M.M.F.
Conterato,Greicy M.M.
Piato,Angelo L.
Gomes,Denise B.
Roman Junior,Walter A.
dc.subject.por.fl_str_mv Antihyperlipidemic
Antiatherogenic
Artichoke
Asteraceae
Cholesterol
topic Antihyperlipidemic
Antiatherogenic
Artichoke
Asteraceae
Cholesterol
description ABSTRACT Cynara scolymus L., Asteraceae, are traditionally used to treat dyspepsia. This study evaluated the hypolipidemic and antiatherogenic effects of an aqueous extract prepared from the leaves of C. scolymus in rat's model. Hypercholesterolemic rats (1% cholesterol and 0.5% cholic acid for 15 days) were treated (0.5 ml/200 g) with extract of C. scolymus (150, 300, or 600 mg/kg p.o.; n = 6) or simvastatin (4 mg/kg p.o.; n = 6) once per day for 30 days along with hypercaloric diet. A control group (C) was given water (0.5 ml/200 g; n = 6). A high-cholesterol diet was maintained throughout the treatment period. Rats treated with extract of C. scolymus (150, 300, or 600 mg/kg) and simvastatin showed significant decreases in serum levels of total cholesterol (−46.9%, −51.9%, −44%, and −41.9%, respectively) and low-density lipoprotein-cholesterol (LDL-C; −52.1%, −54.8%, −51.9%, and −46.7%, respectively), compared with group C (p < 0.005). Biochemical analyses revealed significant decrease in the concentration of IL-1, IL-6, TNF-α, IFN-γ, C-reactive protein, oxidized-LDL, and antioxidized-LDL in rats treated with extract of C. scolymus (150, 300, or 600 mg/kg). There were no differences in serum ALT enzyme activity between the groups. Our results suggest that hypolipidemic and antiatherogenic effects could be related with the presence of polar substances present in aqueous extract of C. scolymus.
publishDate 2016
dc.date.none.fl_str_mv 2016-04-01
dc.type.driver.fl_str_mv info:eu-repo/semantics/article
dc.type.status.fl_str_mv info:eu-repo/semantics/publishedVersion
format article
status_str publishedVersion
dc.identifier.uri.fl_str_mv http://old.scielo.br/scielo.php?script=sci_arttext&pid=S0102-695X2016000200233
url http://old.scielo.br/scielo.php?script=sci_arttext&pid=S0102-695X2016000200233
dc.language.iso.fl_str_mv eng
language eng
dc.relation.none.fl_str_mv 10.1016/j.bjp.2015.11.004
dc.rights.driver.fl_str_mv info:eu-repo/semantics/openAccess
eu_rights_str_mv openAccess
dc.format.none.fl_str_mv text/html
dc.publisher.none.fl_str_mv Sociedade Brasileira de Farmacognosia
publisher.none.fl_str_mv Sociedade Brasileira de Farmacognosia
dc.source.none.fl_str_mv Revista Brasileira de Farmacognosia v.26 n.2 2016
reponame:Revista Brasileira de Farmacognosia (Online)
instname:Sociedade Brasileira de Farmacognosia (SBFgnosia)
instacron:SBFGNOSIA
instname_str Sociedade Brasileira de Farmacognosia (SBFgnosia)
instacron_str SBFGNOSIA
institution SBFGNOSIA
reponame_str Revista Brasileira de Farmacognosia (Online)
collection Revista Brasileira de Farmacognosia (Online)
repository.name.fl_str_mv Revista Brasileira de Farmacognosia (Online) - Sociedade Brasileira de Farmacognosia (SBFgnosia)
repository.mail.fl_str_mv rbgnosia@ltf.ufpb.br
_version_ 1752122469727076352